Annual Reports

Read our Annual Reports

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2022

Introduction

Metrion Biosciences is a specialist ion channel contract research business. We are leaders in the provision of high quality ion channel drug discovery and safety assessment services to the world-wide pharmaceutical and life sciences industry. Founded in September 2015, the Company has established an international reputation for the accuracy and technical competence of its ion channel research and development services and the clarity of its interpretation and reporting.

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2021

Introduction

Metrion Biosciences is a specialist ion channel contract research business. We are leaders in the provision of high quality ion channel drug discovery and safety assessment services to the world-wide pharmaceutical and life sciences industry. Founded in September 2015, the Company has established an international reputation for the accuracy and technical competence of its ion channel research and development services and the clarity of its interpretation and reporting.

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2020

Introduction

Metrion Biosciences is a specialist ion channel contract research business. We are leaders in the provision of high quality ion channel drug discovery and safety assessment services to the world-wide pharmaceutical and life sciences industry. Founded in September 2015, the Company has established an international reputation for the accuracy and technical competence of its ion channel research and development services and the clarity of its interpretation and reporting.

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2019

Introduction

Metrion Biosciences is a specialist ion channel contract research business. We are leaders in the provision of high quality ion channel drug discovery and safety assessment services to the world-wide pharmaceutical and life sciences industry. Founded in September 2015, the Company has established an international reputation for the accuracy and technical competence of its ion channel research and development services and the clarity of its interpretation and reporting.

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2018

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2017

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2016